Statistics
Total Visits
| Views | |
|---|---|
| Effectiveness and safety of daclatasvir/sofosbuvir with or without ribavirin in genotype 3 hepatitis C virus infected patients: results in real clinical practice | 200 |
Total Visits Per Month
| November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Effectiveness and safety of daclatasvir/sofosbuvir with or without ribavirin in genotype 3 hepatitis C virus infected patients: results in real clinical practice | 1 | 7 | 10 | 5 | 4 | 7 | 4 | 3 | 7 | 3 | 1 |
File Visits
| Views | |
|---|---|
| Margusino_Effectiveness.pdf | 44 |
Top country views
| Views | |
|---|---|
| United States | 72 |
| Sweden | 29 |
| Ireland | 21 |
| Spain | 15 |
| Germany | 12 |
| Ukraine | 6 |
| China | 5 |
| Cuba | 5 |
| France | 2 |
| Peru | 2 |
Top cities views
| Views | |
|---|---|
| Louisville | 16 |
| A Coruña | 8 |
| Stockholm | 7 |
| Ann Arbor | 6 |
| Dublin | 6 |
| Fremont | 6 |
| Mountain View | 6 |
| Jacksonville | 5 |
| La Habana | 5 |
| Cambridge | 4 |
